| 3D bioprinting: from benches to translational applications MA Heinrich, W Liu, A Jimenez, J Yang, A Akpek, X Liu, Q Pi, X Mu, N Hu, ... Small 15 (23), 1805510, 2019 | 478 | 2019 |
| 3D in vitro model (R) evolution: unveiling tumor–stroma interactions J Rodrigues, MA Heinrich, LM Teixeira, J Prakash Trends in cancer 7 (3), 249-264, 2021 | 344 | 2021 |
| 3D‐bioprinted mini‐brain: a glioblastoma model to study cellular interactions and therapeutics MA Heinrich, R Bansal, T Lammers, YS Zhang, R Michel Schiffelers, ... Advanced materials 31 (14), 1806590, 2019 | 283 | 2019 |
| Drug targeting to the diseased liver K Poelstra, J Prakash, L Beljaars Journal of controlled release 161 (2), 188-197, 2012 | 204 | 2012 |
| Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery J Schnittert, R Bansal, G Storm, J Prakash Advanced drug delivery reviews 129, 37-53, 2018 | 195 | 2018 |
| Reduction of advanced liver fibrosis by short‐term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats M Moreno, T Gonzalo, RJ Kok, P Sancho‐Bru, M Van Beuge, J Swart, ... Hepatology 51 (3), 942-952, 2010 | 180 | 2010 |
| Targeting the Stat6 pathway in tumor‐associated macrophages reduces tumor growth and metastatic niche formation in breast cancer K Binnemars‐Postma, R Bansal, G Storm, J Prakash The FASEB Journal 32 (2), 969-978, 2018 | 179 | 2018 |
| Drug targeting to myofibroblasts: Implications for fibrosis and cancer S Yazdani, R Bansal, J Prakash Advanced drug delivery reviews 121, 101-116, 2017 | 179 | 2017 |
| Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration DL Priwitaningrum, JBG Blondé, A Sridhar, J van Baarlen, WE Hennink, ... Journal of controlled release 244, 257-268, 2016 | 154 | 2016 |
| Fibrosis imaging: current concepts and future directions M Baues, A Dasgupta, J Ehling, J Prakash, P Boor, F Tacke, F Kiessling, ... Advanced drug delivery reviews 121, 9-26, 2017 | 142 | 2017 |
| Targeting pancreatic stellate cells in cancer J Schnittert, R Bansal, J Prakash Trends in cancer 5 (2), 128-142, 2019 | 137 | 2019 |
| MicroRNA targeting to modulate tumor microenvironment PR Kuninty, J Schnittert, G Storm, J Prakash Frontiers in oncology 6, 3, 2016 | 133 | 2016 |
| Novel engineered targeted interferon‐gamma blocks hepatic fibrogenesis in mice R Bansal, J Prakash, E Post, L Beljaars, D Schuppan, K Poelstra Hepatology 54 (2), 586-596, 2011 | 133 | 2011 |
| Glomerular and tubular induction of the transcription factor c‐Jun in human renal disease MH De Borst, J Prakash, W Melenhorst, MC Van Den Heuvel, RJ Kok, ... The Journal of pathology 213 (2), 219-228, 2007 | 121 | 2007 |
| The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis R Bansal, J Van Baarlen, G Storm, J Prakash Scientific reports 5 (1), 18272, 2015 | 118 | 2015 |
| ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer PR Kuninty, R Bansal, SWL De Geus, DF Mardhian, J Schnittert, ... Science advances 5 (9), eaax2770, 2019 | 115 | 2019 |
| Nanomedicine strategies to target tumor-associated macrophages K Binnemars-Postma, G Storm, J Prakash International journal of molecular sciences 18 (5), 979, 2017 | 115 | 2017 |
| Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles Q Hu, CJ Rijcken, R Bansal, WE Hennink, G Storm, J Prakash Biomaterials 53, 370-378, 2015 | 113 | 2015 |
| Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo DF Mardhian, G Storm, R Bansal, J Prakash Journal of controlled release 290, 1-10, 2018 | 110 | 2018 |
| Clinical advancements in the targeted therapies against liver fibrosis R Bansal, B Nagórniewicz, J Prakash Mediators of inflammation 2016 (1), 7629724, 2016 | 109 | 2016 |